Abstract
Introduction
Botulinum neurotoxins (BoNT) are produced by Clostridium botulinum. BoNT is an extremely potent and lethal biological toxin that blocks neuromuscular transmission by decreasing acetylcholine esterase release. The most common route of exposure to BoNT is through ingestion of contaminated food (Sobel, 2004) . It is estimated that a single gram of crystalline toxin that is evenly dispersed and inhaled could kill more than 1 million people (Arnon et al., 2001) . Estimates of human LD 50 via inhalation is about 3 ng/kg and oral LD 50 is about 6 ng/kg (Burrows, 1999) . Since BoNT can be an extremely potent biotoxin if weaponized (Atlas, 1988; Gill, 1982; Schechter, 2000) , it has been placed on the national select agent registry (USDA, APHIS, & CDC, 2014) . Although some research has developed protective strategies in the case of deliberate contamination of naturally-occurring toxins, an active and continuing push towards protecting public health, especially concerning select agent pathogens and toxins (Burrows, 1999; Janata, 2009; Kendall, 2008 ) is still strong.
Previous work involving BoNT addressed many decontamination scenarios (Burrows, 1999; Horman, 2005) . Others have shown that BoNT/A can be deactivated with 0.1% sodium hypochlorite (Caya, 2004; Siegel, 1993) or by heat at 85ºC for at least 5 minutes to detoxify contaminated food and drink (Siegel, 1993) . Previously, the authors demonstrated the effectiveness of commercially available wipes to clean and decontaminate a surrogate of ricin from the surface of reusable devices and materials used for medical devices (Kulkarni et al., 2013) . In addition, that study noted no clear correlation between the roughness of the surfaces of different materials and the retention of the ricin surrogate on the surfaces (Kulkarni et al., 2013) .
Thus far, no studies specifically address decontamination of medical devices that have been tainted with BoNT. Decontamination is defined as the use of physical or chemical means to remove, inactivate, or kill pathogenic organisms on surfaces or items so that they are rendered safe for handling, use, or disposal (AAMI, 2010) . External surfaces of reusable devices and equipment can be contaminated either accidentally or intentionally by microbial pathogens or natural toxins. Dried BoNT on device surfaces can be accidentally inhaled or ingested by patients and healthcare providers or come in contact with the gloved hand of the healthcare personnel, which in turn may contact mucosal surfaces in the nose, mouth, and eyes, or by an accidental needle stick injury (CDC, 2009 ). Medical personnel caring for patients who have botulism are advised to use standard precautions. Transfer of toxins from medical device surfaces to healthcare worker and subsequently to patients should be minimized (Atlas, 1998) .
The objective of this study was to measure the remaining enzymatic activity of BoNT/A, using LcA as a surrogate, on different materials used in medical devices and on the surfaces of five reusable medical devices-an anesthesia machine, two different types of ventilators, and two different types of hospital bed rails. The influence of surface roughness on BoNT/A was evaluated by measuring the remaining enzymatic activity of LcA.
Materials and Methods

Chemicals
The distilled deionized water used in this study was produced with a Barnstead NANOpure Diamond water purification unit (ThermoScientific Inc, Rockford, IL). SNAPtide ® (FITC/DABCYL) peptide (a labeled peptide that is a substrate for BoNT/A) and Type A Light Chain (LcA) were purchased from List Biological Laboratories, Inc. (Campbell, CA). BactiSwabs, used to remove the LcA from surfaces, were purchased from Remel (Lenexa, KS). HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) was obtained from Sigma Aldrich (St. Louis, MO).
Detection of Surrogate for BoNT/A
The SNAP-25 assay, as described by Sapsford et al. (2008) , was used to detect the enzymatically active light chain A (LcA) portion of BoNT/A, and served as a surrogate for the entire toxin. Briefly, in a white polystyrene microtiter plate (Corning #3990, Corning Inc., Corning, NY), 50 μl of a 10 μM SNAPtide ® was added to 100 μl of a sample or standard in 20 mM HEPES buffer pH 8.2. After incubation at room temperature for approximately 90 minutes, plates were read on a fluorescent plate reader at excitation 490 nm, emission 523 nm (Tecan Infinte M1000 with iControl software; Tecan Group Ltd., Männedorf, Switzerland).
Preparation of Polymeric and Metal Material Surfaces
The ultrahigh molecular weight polyethylene (UHMWPE), stainless steel (SS), and polypropylene (PPE) materials were selected from a list of materials commonly used to manufacture medical devices (Jenke, 2009 ). These materials were ordered from Smallparts.com Inc. (now a part of Amazon.com, Inc.) and were non-medical grade. The roughness of these three different medical device material surfaces were physically altered by either glass beading or sandpaper (60 grit for plastics, 40 grit for stainless steel), or by sanding with Scotch-Brite™ in the machine shop at the U.S. Food and Drug Administration (FDA) White Oak facility in Maryland. The three different materials of altered roughness, and one of unaltered roughness, were then cut to 2 cm x 4 cm sizes. The surfaces of all the materials tested for BoNT/A removal were first cleaned by washing with a detergent for laboratory glassware followed by rinsing under running deionized water for 10 seconds to remove any surface debris or contaminants and then air dried overnight in a biological safety cabinet. Three separate experiments with 3-5 samples per experiment were conducted for each material roughness.
Application of LcA to Material Surfaces
Evaluation of LcA stability in solution with different materials: First, the interaction of LcA with the three test materials (PPE, UHMWPE, and SS) while in solution was determined. A small corner of the 2 cm x 4 cm of each material test piece (PPE, UHMWPE, and SS) was cut off
(an approximately 7-12 mm 2 area) and placed in 1 mL of 10 nM LcA in a polypropylene test tube. The positive control was 10 nM LcA with no material. 100 μl aliquots were removed at 0, 30, 60, and 90 minutes and placed in a white polystyrene microtiter plate. Following addition of the final sample, the standard SNAPtide ® assay was performed. Evaluation of LcA stability when dried on different materials: To a 2 cm x 4 cm rectangle of the test material, 5 μL of 10 nM LCA was spotted and allowed to dry overnight (about 18 hours) at room temperature. The negative control was spotted with 5 μL of 20 nM HEPES buffer. The following day, a BactiSwab was submerged in 0.5 ml of 20 mM HEPES buffer pH 8.2 within a 15 ml polypropylene test tube. This swab was then used to take a sample from the 2 cm x 4 cm coupon. After swabbing, the BactiSwab was placed back into the same tube in which it was submerged. The test tube was vortexed for about 5 seconds, and then aliquots for analysis were placed in the white polystyrene microtiter plate for LcA determination using the SNAP assays.
The effect of drying on the enzymatic activity was determined by placing small aliquots of the LcA in a 96-well plate overnight (about 18 hours) or for 2 hours at room temperature and the SNAP assay signal of the dried LcA samples was compared to that of freshly made LcA. Addition of a BactiSwab (dry) to dilutions of LcA in 20 mM HEPES were prepared to assess any influence of the swab on the activity of the BoNT/A surrogate. To evaluate the effect of the material on drying LcA, 5 μL of 10 nM LcA was placed on small triangles (about 0.5 cm 2 ) of each of the materials (PPE, UHMWPE, and SS) and dried overnight (about 18 hours). The following day, 0.5 ml of 20 mM HEPES buffer was added to each sample, which submerged the entire material, vortexed for at least 15 seconds, and assayed for LcA activity.
Reusable Medical Device Surfaces
The following reusable medical devices were tested for the percent removal of LcA-an anesthesia machine, a stationary ventilator, a portable ventilator, one stainless steel hospital bed rail, and one plastic hospital bed rail. The horizontal surfaces of the medical devices were spotted and swabbed in the same manner as the material surfaces and the extracts were analyzed as described above to determine percent removal of LcA. Three separate experiments with 3-5 samples per experiment were conducted for each medical device surface.
Surface Roughness
The surface roughness of the test surface was measured using a Bruker Contour GR-K1 3D Optical Microscope (Bruker Nano Surface Division, Tucson, AZ). Using the Vertical Scanning Interferometry (VSI) mode with white light at 10x magnification, four measurements were made from each side of the test surface with a minimum of seven specimens measured for each material and surface. For the reusable medical device surfaces, a Mitutoyo SJ-400 Portable Surface Roughness Tester (Mitutoyo America Corporation, Chicago, IL) was used.
Statistical Analysis
Both Student's t-tests and one-way ANOVA were used to determine if there was any significant difference among samples and groups of samples for the amount of LcA removed.
Results
Detection of Surrogate for BoNT/A
Commercially available BoTox ® was tested using both commercially available antibodies and the SNAPtide ® assay. The level of NT/A in the BoTox ® was below the limit of detection of antibodies and the SNAPtide ® assays (data not shown). Commercially available, enzymatically active light chain of BoNT/A (LcA) was used as a surrogate for the entire protein toxin. The SNAPtide ® assay detected the purified light chain of NT/A with a limit of detection of ~1 nM.
Polymeric and Metal Material Surfaces
Placing small pieces of the individual materials in a solution of 10 nM LcA, with LcA alone as the control, indicated some interaction by both polypropylene and polystyrene test tubes with the LcA activity (Table 1) . This was not due to a decrease in LcA activity because when the sample was removed at time 0 in the absence of material, no decrease in enzymatic activity occurred after being transferred into the microtiter plate. Similar results were seen when polystyrene test tubes were used (data not shown). There are different types of polystyrene material with different physical and chemical properties (Gray, 2011) ; the material of the white polystyrene microtiter plates was different from that of the polystyrene test tubes. After documenting the decrease in LcA activity over these short periods of time (30 minutes) while in polypropylene or polystyrene test tubes, all swabbings of LcA dried on medical devices or material surfaces were vortexed and placed in a microtiter plate within a few minutes.
LcA and Material Surfaces
No statistically significant difference was noted among the amounts of LcA removed from any of the materials with four different types of roughness for all the materials that were tested (Table 2 ). However, a strong, but not significant, trend for the removal of LcA from the SS material Articles   Table 1 The effect of time on the activity of LcA in solution in polypropylene test tubes alone or with materials: stainless steel (SS), polypropylene (PPE) and ultrahigh molecular weight polyethyelene (UHMWPE). All data are expressed as a percent of no material added to LcA at time 0. Table 2 A summary of the recovery and roughness of medical device materials used in this study (PPE (polypropylene), UHMWPE (ultrahigh molecular weight polyethylene) SS (stainless steel)). The roughness of these three different medical device material surfaces were physically altered by either glass beading, sandpaper (60 grit for plastics, 40 grit for stainless steel), or by sanding with Scotch-Brite™. Student's t-Test indicated no significant difference in the amount of LcA removed from the different materials, or any significant difference in removal of LcA from the same material of different roughness. Data were not corrected for loss of activity due to dryings. was evident; the smoothest SS had twice the LcA activity of the rougher three SS materials.
TIME (min)
Reusable Medical Device Surfaces
No statistically significant difference was noted among the amounts of LcA recovered from the surface of any of the five different medical devices (Table 3) . It should be noted that the drying of LcA on these medical devices and materials was not exactly the same in time, temperature, or relative humidity; all samples were dried overnight for about 18 hours at room temperature and humidity.
Discussion Detection of BoNT/A
As neither commercially available antibodies nor labeled peptide substrate (SNAPtide ® ) was able to detect NT/ A in commercially available BoTox ® , the light chain Type A (LcA) of NT/A served as a surrogate for the entire protein toxin, and the SNAPtide ® assay as the detection system. Comparison of a series of dilutions of LcA in BoTox ® to that of LcA alone showed no difference in the SNAP assay, indicating there is no affect of the BoTox ® formulation on this assay. Rather, this suggests that the level of NT/A in the commercial preparation of BoTox ® is simply below the limit of detection for this peptide assay, which is approximately 1 nM. The choice of the SNAPtide ® assay versus commercially available antibodies was not just a selection of assay sensitivity, but rather the use of LcA as the surrogate dictated the detection system.
Initially, small aliquots (10 μl) LcA were dried in a 96-well plate overnight or for 2 hours at room temperature, and the enzymatic activity of the dried LcA samples were compared to that of freshly made LcA. The activity of these samples, whether dried overnight or for 2 hours, was 82% of the activity of freshly made LcA, indicating that quickly drying a small aliquot (10 μl) did not largely affect the enzymatic activity of LcA. The presence of a BactiSwab (dry) to dilutions of LcA in 20 mM HEPES did not affect the activity or recovery of the LcA. However, placing the LcA while in solution in a polystyrene or polypropylene test tube for more than a few minutes did decrease the activity of the LcA. This suggests some interaction of the enzymatic LcA with the plastics when in solution (Table 1) . If the material samples were extracted within a few minutes, recovery of the LcA exceeded 90%. The effect of the material on the drying LcA overnight on small triangles of the materials (0.5 cm 2 ), PPE, UHMWPE, and SS, indicated that about 50% of the LcA activity was lost. The remaining enzymatic activity of LcA dried on medical device materials was 14% to 41%, while that of LcA dried on medical devices ranged from 36% to 71%. This wide range of remaining enzymatic activity may be affected by numerous factors such as normal variation in ambient temperature (22ºC+3ºC), relative humidity (50%+10%), and changes in the laboratory air flow. A consensus review of BoNT noted that depending on the temperature and humidity, aerosolized toxin has been estimated to decay at the rate of less than 1%-4% per minute (Arnon, 2001) . The results of this study showed the loss of enzymatic activity of LcA dried on the surfaces was much less than this estimate for aerosolized BoNT. The LcA was left on the device or surface for about 18 hours; if the decay of dried LcA was similar to the aerosolized toxin, the recovery of activity would be in the 0.1% range. It appears this form of toxin dissemination is more stable than that of the solely airborne BoNT.
Polymeric and Metal Material Surfaces
If a material surface is accidentally or deliberately contaminated, determining if it can be easily decontaminated to make it safe for subsequent use is important. A practical method to detect the amount of toxin and the effectiveness of decontamination may be to swab the surface (Hodges, 2010; U.S. FDA, 2013) , extract the swab, and then test for the amount of toxin in the extract. Furthermore, determining how much BoNT/A can be removed from a surface is useful. This study measured the enzymatic activity of LcA removed from the contaminated surface by swabbing and evaluated if certain materials, or the roughness of the same material, enhanced or inhibited the removal of LcA. Swabbing the surface a second time did not remove significantly more LcA. Less than 10% of the initial activity was obtained in the second swab. Although the influence of the roughness of a surface in removing microbes (Bollen, 1997) has been studied, the effect of roughness on the removal of bacterial toxins as related to medical device materials has not been well characterized. In this study, it appears the various micrometer differences in surface roughArticles Table 3 The amount of LcA swabbed after drying overnight from the surfaces of five different reusable medical device instruments. Data were not corrected for loss of activity due to drying. ness did not play a significant role in the removal of small protein toxins like LcA (Table 2) .
Reusable Medical Device Surfaces
Whether a device is accidentally or deliberately contaminated, cleaning the contaminant from the surfaces is important for the safety of both the next patient and the healthcare provider (AAMI, 2010) . This study showed there was no statistically significant difference in the remaining enzymatic activity of LcA on any of the reusable medical device surfaces examined (Table 3 ). The difference, or lack thereof, in the results for cleaning medical device surfaces may be impacted by unmeasured factors, such as a coating or colorant, on the polymeric surface of the medical devices used.
Conclusion
While it is known that reverse osmosis water filtration successfully filters BoNT/A from water (Horman, 2005) and sodium hypochlorite is effective in denaturing BoNT/A (Caya, 2004) , the remaining activity of BoNT/A on the surface of reusable medical devices had not been evaluated. In the event of BoNT contamination, hospitals could face significant challenges in treating patients while also protecting healthcare workers (Atlas, 1998) . The objective of this study was to examine the remaining enzymatic activity of LcA of BoNT/A on contaminated surfaces. After drying overnight, the amount of active LcA remaining on the surface of medical device material ranged from 14%-41% and from medical device surfaces ranged from 36%-71%. Swabbing the medical devices and materials a second time yielded less than 10% LcA of the amount obtained in the initial swabbing, indicating physical removal of the LcA is an important component in decontamination. Because the roughness of a surface can affect the retention of organic debris, micrometer differences in surface roughness that reflect the roughness of medical devices were also evaluated. The different roughness models and various medical device surfaces used in this study showed that there was no statistically significant difference in the removal of LcA. However, the actual disposition of the whole BoNT on the surface of medical devices or materials may differ.
